“…9, 10 The use of constrained peptides or peptide mimics has become popular for increasing receptor affinity, for the development of new drugs, to investigate bioactive conformations, and to increase duration of action. On native peptides, constraints can be introduced by linkage between two points of the peptide (NH to NH, 11 NH to CO 2 H 12 or disulfide bridge 13 ) to fix a large secondary structure, generally a helix or sheets. The small secondary structures (turn, small helix, hairpin and E-or Z-amide bonds) can also be induced, stabilized or fixed by introduction in the sequence of one or several small constrained (Freidinger lactams 14 or azabicycloalkanes 15, 16 ), bulky (alkylprolines 17 ) or rigid (dipeptide isosteres 18,19 ) unnatural amino acids.…”